Discover trends, market shifts, and competitive outlooks for the cancer biopsy industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Cancer Biopsy Market In 2029?

The market size of cancer biopsy has been on an accelerated expansion track in the past few years. The market is expected to surge from $25.08 billion in 2024 to $28.52 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.7%. The notable growth in the previous period can be linked to a heightened consciousness about breast cancer liquid biopsy techniques, growing knowledge about inherited cancer conditions and genetic assessments, wider acceptance of liquid biopsies, as well as a growing demand for minimally invasive biopsy treatments and tissue biopsies.

The market size for cancer biopsies is projected to experience a significant expansion in the coming years, reaching a total of $47.2 billion by 2029 with a compound annual growth rate (CAGR) of 13.4%. Factors contributing to this prediction for growth during the forecast period include a rise in patient numbers, an aging population, an increase in suspected breast cancer patients, and a surge in overall cancer cases. The growth is also due to an increase in diagnosis and biopsy testing, as well as a larger patient base. Key trends for the forecast period involve progressing technology, the use of artificial intelligence and machine learning, the integration of multi-omics, new innovative products, and point-of-care biopsy devices.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19355&type=smp

Which Factors and External Forces Are Driving Demand in the Cancer Biopsy Market?

The surge in cancer cases is forecasted to fuel the expansion of the cancer biopsy market. Cancer consists of a series of diseases manifested by the unusual proliferation and distribution of cells. Factors contributing to the surge in cancer incidence include shifts in lifestyle and urbanization, environmental toxins, consumption of tobacco and alcohol, availability of healthcare and awareness. Cancer biopsies are instrumental in diagnosing and evaluating the type, stage, and spread of cancer by procuring and examining tissue or cells from a suspicious region. For example, as reported by the National Center for Biotechnology Information, a U.S. intergovernmental organization, in January 2023, the U.S. recorded 1,958,310 new cancer diagnoses and 609,820 cancer-related fatalities. The National Library of Medicine, a U.S. medicine library, stated in May 2021 that the global cancer burden is predicted to reach 28.4 million cases in 2040, indicating a 47% increase from 2020, accompanied by a huge death toll. Consequently, the rising incidence of cancer propels the cancer biopsy market.

Which Segments in the Cancer Biopsy Offer the Most Growth?

The cancer biopsymarket covered in this report is segmented –

1) By Type: Tissue Biopsies, Liquid Biopsies, Other Types

2) By Application: Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Other Applications

3) By End User: Hospitals, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Tissue Biopsies: Core Needle Biopsies, Fine Needle Aspiration (FNA) Biopsies, Incisional Biopsies, Excisional Biopsies

2) By Liquid Biopsies: Circulating Tumor Cell (CTC) Analysis, Circulating Tumor DNA (ctDNA) Testing, Plasma Biomarker Testing

3) By Other Types: Bone Biopsies, Endoscopic Biopsies, Brush Biopsies, Skin Biopsies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=19355&type=smp

What Are the Fastest-Growing Geographies in the Cancer Biopsy Market?

North America was the largest region in the cancer biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive the Cancer Biopsy Market’s Growth?

Leading organizations in the cancer biopsy industry are focusing on the development of liquid biopsy technologies for non-invasive early identification and monitoring of cancers, enhancing patient recovery and facilitating more personalized treatment plans. Liquid biopsy is a progressive diagnostic method that examines genetic materials extracted from a blood test, including circulating tumor DNA (ctDNA), RNA, exosomes and other biomarkers. For example, in May 2023, Labcorp, an American firm with expertise in creating cancer biopsies, introduced the Labcorp Plasma Focus, a plasma-centric liquid biopsy for the identification of cancer-related biomarkers. This test inspects circulating cell-free DNA (cfDNA) shed by tumor cells into the bloodstream and generates a genomic profile of the patient’s tumor. It identifies anomalies across 33 genes associated with several cancers, comprising non-small cell lung cancer, colorectal cancer, breast cancer, esophageal cancer, and melanoma.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cancer-biopsy-global-market-report

What Are the Key Elements That Define the Cancer Biopsy Market?

A cancer biopsy is a medical procedure that involves the removal of a small sample of tissue or cells from a suspicious area of the body to determine the presence of cancer or other conditions. This procedure is essential for diagnosing cancer, as imaging tests such as computed tomography (CT) scans or magnetic resonance imaging (MRI) cannot definitively differentiate between cancerous and non-cancerous cells.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19355

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model